|
|
|
|
|
|
|
|
To improve the lives of alpha-1-antitrypsin deficient individuals
and their families through research and service by:
|
- Developing new therapies that target lung and liver disease associated with alpha-1-antitrypsin deficiency using a combination of basic and clinical research
- Removing significant impediments to research by developing shared resources
- Developing and utilizing cutting edge technologies to improve the early identification of individuals with alpha-1-antitrypsin deficiency
- Providing clinics devoted to the care of alpha-1-antitrypsin deficient individuals with lung and liver disease.
|
|
|
|
|
